141 related articles for article (PubMed ID: 10995878)
1. A study of SPARC and vitronectin localization and expression in pediatric and adult gliomas: high SPARC secretion correlates with decreased migration on vitronectin.
Menon PM; Gutierrez JA; Rempel SA
Int J Oncol; 2000 Oct; 17(4):683-93. PubMed ID: 10995878
[TBL] [Abstract][Full Text] [Related]
2. SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins.
Rempel SA; Golembieski WA; Fisher JL; Maile M; Nakeff A
J Neurooncol; 2001 Jun; 53(2):149-60. PubMed ID: 11716067
[TBL] [Abstract][Full Text] [Related]
3. Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo.
Schultz C; Lemke N; Ge S; Golembieski WA; Rempel SA
Cancer Res; 2002 Nov; 62(21):6270-7. PubMed ID: 12414657
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of SPARC expression inhibits cell migration and invasion in malignant gliomas.
Seno T; Harada H; Kohno S; Teraoka M; Inoue A; Ohnishi T
Int J Oncol; 2009 Mar; 34(3):707-15. PubMed ID: 19212676
[TBL] [Abstract][Full Text] [Related]
5. HSP27 mediates SPARC-induced changes in glioma morphology, migration, and invasion.
Golembieski WA; Thomas SL; Schultz CR; Yunker CK; McClung HM; Lemke N; Cazacu S; Barker T; Sage EH; Brodie C; Rempel SA
Glia; 2008 Aug; 56(10):1061-75. PubMed ID: 18442089
[TBL] [Abstract][Full Text] [Related]
6. Targeting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC.
Vajkoczy P; Menger MD; Goldbrunner R; Ge S; Fong TA; Vollmar B; Schilling L; Ullrich A; Hirth KP; Tonn JC; Schmiedek P; Rempel SA
Int J Cancer; 2000 Jul; 87(2):261-8. PubMed ID: 10861485
[TBL] [Abstract][Full Text] [Related]
7. Deletion of the SPARC acidic domain or EGF-like module reduces SPARC-induced migration and signaling through p38 MAPK/HSP27 in glioma.
McClung HM; Golembieski WA; Schultz CR; Jankowski M; Schultz LR; Rempel SA
Carcinogenesis; 2012 Feb; 33(2):275-84. PubMed ID: 22114076
[TBL] [Abstract][Full Text] [Related]
8. SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretion.
Yunker CK; Golembieski W; Lemke N; Schultz CR; Cazacu S; Brodie C; Rempel SA
Int J Cancer; 2008 Jun; 122(12):2735-43. PubMed ID: 18350569
[TBL] [Abstract][Full Text] [Related]
9. Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases.
Shi Q; Bao S; Song L; Wu Q; Bigner DD; Hjelmeland AB; Rich JN
Oncogene; 2007 Jun; 26(28):4084-94. PubMed ID: 17213807
[TBL] [Abstract][Full Text] [Related]
10. PTEN augments SPARC suppression of proliferation and inhibits SPARC-induced migration by suppressing SHC-RAF-ERK and AKT signaling.
Thomas SL; Alam R; Lemke N; Schultz LR; Gutiérrez JA; Rempel SA
Neuro Oncol; 2010 Sep; 12(9):941-55. PubMed ID: 20472716
[TBL] [Abstract][Full Text] [Related]
11. PTEN suppresses SPARC-induced pMAPKAPK2 and inhibits SPARC-induced Ser78 HSP27 phosphorylation in glioma.
Alam R; Schultz CR; Golembieski WA; Poisson LM; Rempel SA
Neuro Oncol; 2013 Apr; 15(4):451-61. PubMed ID: 23382286
[TBL] [Abstract][Full Text] [Related]
12. SPARC: a signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas.
Rempel SA; Golembieski WA; Ge S; Lemke N; Elisevich K; Mikkelsen T; Gutiérrez JA
J Neuropathol Exp Neurol; 1998 Dec; 57(12):1112-21. PubMed ID: 9862633
[TBL] [Abstract][Full Text] [Related]
13. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.
Koga K; Todaka T; Morioka M; Hamada J; Kai Y; Yano S; Okamura A; Takakura N; Suda T; Ushio Y
Cancer Res; 2001 Aug; 61(16):6248-54. PubMed ID: 11507079
[TBL] [Abstract][Full Text] [Related]
14. Secreted protein, acidic and rich in cysteine (SPARC) expression in astrocytic tumour cells negatively correlates with proliferation, while vascular SPARC expression is associated with patient survival.
Capper D; Mittelbronn M; Goeppert B; Meyermann R; Schittenhelm J
Neuropathol Appl Neurobiol; 2010 Apr; 36(3):183-97. PubMed ID: 20132490
[TBL] [Abstract][Full Text] [Related]
15. SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells.
McClung HM; Thomas SL; Osenkowski P; Toth M; Menon P; Raz A; Fridman R; Rempel SA
Neurosci Lett; 2007 May; 419(2):172-7. PubMed ID: 17490812
[TBL] [Abstract][Full Text] [Related]
16. cDNA array analysis of SPARC-modulated changes in glioma gene expression.
Golembieski WA; Rempel SA
J Neurooncol; 2002 Dec; 60(3):213-26. PubMed ID: 12510773
[TBL] [Abstract][Full Text] [Related]
17. SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA.
Kunigal S; Gondi CS; Gujrati M; Lakka SS; Dinh DH; Olivero WC; Rao JS
Int J Oncol; 2006 Dec; 29(6):1349-57. PubMed ID: 17088972
[TBL] [Abstract][Full Text] [Related]
18. SPARC affects glioma cell growth differently when grown on brain ECM proteins in vitro under standard versus reduced-serum stress conditions.
Vadlamuri SV; Media J; Sankey SS; Nakeff A; Divine G; Rempel SA
Neuro Oncol; 2003 Oct; 5(4):244-54. PubMed ID: 14565160
[TBL] [Abstract][Full Text] [Related]
19. Patterns of SPARC expression and basement membrane intactness at the tumour-brain border of invasive meningiomas.
Schittenhelm J; Mittelbronn M; Roser F; Tatagiba M; Mawrin C; Bornemann A
Neuropathol Appl Neurobiol; 2006 Oct; 32(5):525-31. PubMed ID: 16972886
[TBL] [Abstract][Full Text] [Related]
20. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma.
Rempel SA; Dudas S; Ge S; Gutiérrez JA
Clin Cancer Res; 2000 Jan; 6(1):102-11. PubMed ID: 10656438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
